Clinical trial
Double Blind Randomized Study Comparing Ibandronate Versus Placebo in Hip Osteonecrosis Stage 1 and 2
NCT02114489 is registered in ClinicalTrials.gov with Brigitte Jolles, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double Blind Randomized Study Comparing Ibandronate Versus Placebo in Hip Osteonecrosis Stage 1 and 2
- Lead sponsor
- Brigitte Jolles, MD
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- June 30, 2014
- Completion date
- March 31, 2017
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aseptic hip necrosis, hip necrosis